To investigate if the effects of CXCR4 hyperactivation on B-cell leukemia and lymphoma development and dissemination are B cell intrinsic, we isolated splenocytes of pre-malignant animals and assessed their migratory capacity in response to CXCL12 ex vivo. The gene discussed is CXCL12; the disease is lymphoma.